Related Experiment Video
Updated: Jun 4, 2026

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
Published on: December 27, 2016
mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif
You-Tong Wu1, Weiming Ouyang, Adam S Lazorchak
1Department of Immunobiology and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Abstract:
The protein kinase Akt (also known as protein kinase B) is a critical signaling hub downstream of various cellular stimuli such as growth factors that control cell survival, growth, and proliferation. The activity of Akt is tightly regulated, and the aberrant activation of Akt is associated with diverse human diseases including cancer. Although it is well documented that the mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of the Akt hydrophobic motif (Ser-473 in Akt1) is essential for full Akt activation, it remains unclear whether this phosphorylation has additional roles in regulating Akt activity. In this study, we found that abolishing Akt Ser-473 phosphorylation stabilizes Akt following agonist stimulation. The Akt Ser-473 phosphorylation promotes a Lys-48-linked polyubiquitination of Akt, resulting in its rapid proteasomal degradation. Moreover, blockade of this proteasomal degradation pathway prolongs agonist-induced Akt activation. These data reveal that mTORC2 plays a central role in regulating the Akt protein life cycle by first stabilizing Akt protein folding through the turn motif phosphorylation and then by promoting Akt protein degradation through the hydrophobic motif phosphorylation. Taken together, this study reveals that the Akt Ser-473 phosphorylation-dependent ubiquitination and degradation is an important negative feedback regulation that specifically terminates Akt activation.
Insights
Akt phosphorylation at Ser-473 by mTORC2 targets the protein for degradation. This process, involving ubiquitination, acts as a negative feedback loop to terminate Akt signaling, crucial for cell growth and cancer.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Biochemistry
Background:
- Akt (Protein Kinase B) is a key regulator of cell survival, growth, and proliferation.
- Aberrant Akt activation is linked to human diseases, notably cancer.
- mTORC2-dependent phosphorylation of Akt at Ser-473 is vital for full Akt activation.
Purpose of the Study:
- To investigate the role of Akt Ser-473 phosphorylation beyond full Akt activation.
- To elucidate the regulatory mechanisms controlling Akt protein stability and signaling duration.
Main Methods:
- Investigated the impact of abolishing Akt Ser-473 phosphorylation on Akt stability.
- Analyzed Akt ubiquitination and proteasomal degradation pathways.
- Examined the effect of blocking proteasomal degradation on agonist-induced Akt activation.
Main Results:
- Abolishing Akt Ser-473 phosphorylation stabilizes Akt after stimulation.
- Akt Ser-473 phosphorylation promotes Lys-48-linked polyubiquitination, leading to proteasomal degradation.
- Inhibiting proteasomal degradation extends agonist-induced Akt activation.
Conclusions:
- mTORC2 regulates the Akt protein life cycle through both stabilization (turn motif) and degradation (hydrophobic motif phosphorylation).
- Akt Ser-473 phosphorylation-dependent ubiquitination and degradation serve as a negative feedback mechanism to terminate Akt activation.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
